绝经后妇女尿生殖障碍发生率高达73％,严重影响生活质量。本文对天然雌三醇(E_3)制剂ovestin治疗绝经后尿生殖障碍过程中尿路和生殖道的状态进行了如下研究。对象与方法研究对象为46例平均60±0.46岁的绝经后尿生殖障碍妇女,绝经后5～11年,患尿生殖障碍长达2年者21例。2年以上者25例。用药 The prevalence of urogenital disorders in postmenopausal women is as high as 73%, seriously affecting the quality of life. In this paper, the status of urinary tract and genital tract in the treatment of postmenopausal urogenital disorders by ovestin, a natural estriol (E_3), was studied as follows. Subjects and Methods The subjects were 46 women with an average of 60 ± 0.46 years of age with post-menopausal urogenital disorders, 21 with post-menopausal 5 to 11 years and those with urogenital disorders up to 2 years. 25 cases over 2 years. Medication